M3D Receives NSF SBIR Phase I Grant to Advance Gamma Camera Design
GreenMark Announces Distribution Partnership with Great Oral
Peptinovo Biopharma raises $1.4 million in Series A funding, begins campaign to raise $10 million to enhance cancer treatment
Shionogi and Jordan’s Guardian Angels Announce First-Ever Human Drug Study for Jordan’s Syndrome, an Ultra-Rare Genetic Neurodevelopmental Disorder
EVOQ Therapeutics Secures $2 Million in Funding for Advanced Autoimmune NanoDisc Therapies
https://investors.seastarmedical.com/news/news-details/2025/FDA-Approves-Feasibility-Study-with-SeaStar-Medicals-Selective-Cytopheretic-Device-in-Adults-with-Cardiorenal-Syndrome/default.aspx
https://www.onltherapeutics.com/2024/09/13/onl-therapeutics-closes-65-million-in-oversubscribed-series-d-financing/
HAPPE Spine Announces FDA Clearance for the INTEGRATE™-C Interbody Fusion System
ONL Therapeutics Announces First Patient Dosed in Phase 2 Clinical Trial of First-in-Class Fas-Inhibitor in Patients with Macula-Off Rhegmatogenous Retinal Detachmenton
NASDAQ celebrates Shoulder Innovations
